HematologyNews.net

Hematology Xagena

Search results for "Follicular lymphoma"

Researchers at The University of Texas M. D. Anderson Cancer Center and the National Cancer Institute have found that an experimental vaccine can prime the immune system to help fight an aggressive fo ...


A Phase II clinical study demonstrated that Galiximab may be used in combination with Rituximab ( Rituxan ), and the combination may prolong event-free survival ( EFS ) in patients with relapsed or re ...


Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a study presented at the 50th Annual Meeting of the American So ...


Radioimmunotherapy with the radioactive drug Yttrium-90 ( 90Y ) Ibritumomab tiuxetan ( Zevalin ), following chemotherapy with Fludarabine ( Fludara ) and Mitoxantrone ( Novantrone ), is feasible, well ...


Novel treatments have shown improvements in survival and response rates for leukemia and lymphoma. The use of Dexamethasone early in the treatment of children with acute lymphoblastic leukemia, the ...


Treating relapsed follicular lymphoma patients with a milder chemotherapy regimen before they receive a blood stem cell transplant from a donor resulted in long-term complete remission for 45 of 47 pa ...


Radioimmunotherapy with the radioactive drug Yttrium-90 ( 90Y ) Ibritumomab tiuxetan ( Zevalin ), following chemotherapy with Fludarabine ( Fludara ) and Mitoxantrone ( Novantrone ), is feasible, well ...


A second generation, highly targeted monoclonal antibody appears to provide benefit for some patients with follicular lymphoma for whom other treatments have failed, according to results of a phase I ...


Statins, drugs widely prescribed to lower cholesterol, do not interfere with a commonly used medication to treat lymphomas, according to a study presented at the 50th Annual Meeting of the American ...


A new study has found for the first time that maintenance therapy with the novel antibody, Rituximab ( MabThera, Rituxan ) following Cyclophosphamide, Vincristine and Prednisone ( CVP ) therapy improv ...


The study enrolled patients with chronic lymphocytic leukemia ( CLL ), heavily pre-treated, who did not respond to, or who were ineligible for, currently available treatment options such as Fludarabin ...


A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, researchers at T ...


Ofatumumab ( Arzerra ) is a fully human monoclonal antibody that binds to both the large and small extracellular loops of CD20. Ofatumumab is currently approved for patients with refractory chronic ly ...


Early results of a randomized phase III GITMO/FIL study comparing CHOP-R vs. R-HDS + ASCT as primary treatment in 134 FL pts, aged less than or equal to 60 yrs with aaIPI greater than 1/IIL score grea ...


Phosphatidylinositol-3-kinase delta ( PI3Kδ ) mediates B-cell receptor signaling and microenvironmental support signals that promote the growth and survival of malignant B lymphocytes. In a phase 1 ...